Skip to main content
SpringerLink
Log in

Auge und Schwangerschaft

Eye and pregnancy

  • CME Weiterbildung · Zertifizierte Fortbildung
  • Published:
Der Ophthalmologe Aims and scope Submit manuscript

Zusammenfassung

Während der Schwangerschaft kommt es am Auge zu einer Reihe von Umstellungsreaktionen. So kann sich beispielsweise die Refraktion ändern oder eine Kontaktlinsenunverträglichkeit einstellen. Einige Erkrankungen können voranschreiten. Hier ist vor allen Dingen die diabetische Retinopathie zu nennen, welche die häufigste Augenerkrankung in der Schwangerschaft ist. Das Risiko einer Progression der Retinopathie ist abhängig vom Status vor der Schwangerschaft. Die Behandlung entspricht hinsichtlich der Proliferation der von nicht schwangeren Diabetikerinnen.

Eine Spontanentbindung ist nahezu immer möglich. Ein Kaiserschnitt wegen Myopie, Netzhautdegenerationen oder nach Netzhautoperation ist nicht erforderlich. Viele der üblichen lokalen Medikamente können am Auge auch während der Schwangerschaft ohne erhöhtes Fehlbildungsrisiko eingesetzt werden.

Abstract

Pregnancy may cause ocular changes, for example refractive changes or contact lens intolerance. A number of ocular diseases may deteriorate. Especially preexisting diabetic retinopathy may worsen. Vaginal delivery is nearly always possible. Caesarean section is not required due to myopia, peripheral retinal degenerations or after retinal surgery. Most topically applied drugs usually used in ophthalmology are safe during pregnancy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3
Abb. 4

Literatur

  1. Sunness JS (1988) The pregnant woman’s eye. Surv Ophthalmol 32:219–238

    Article  CAS  PubMed  Google Scholar 

  2. Weinreb RN, Lu A, Key T (1987) Maternal ocular adaptations during pregnancy. Obstet Gynecol Surv 42:471–483

    Article  CAS  PubMed  Google Scholar 

  3. Sharma S, Rekha W, Sharma T, Downey G (2006) Refractive issues in pregnancy. Aust N Z J Obstet Gynaecol 46:186–188

    Article  PubMed  Google Scholar 

  4. Duncan TE (1974) Krukenberg spindles in pregnancy. Arch Ophthalmol 91:355–358

    CAS  PubMed  Google Scholar 

  5. Funk J (1997) The eye and pregnancy. Ophthalmologe 94:53–63

    Article  CAS  PubMed  Google Scholar 

  6. Sheth BP, Mieler WF (2001) Ocular complications of pregnancy. Curr Opin Ophthalmol 12:455–463

    Article  CAS  PubMed  Google Scholar 

  7. Rabiah PK, Vitale AT (2003) Noninfectious uveitis and pregnancy. Am J Ophthalmol 136:91–98

    Article  PubMed  Google Scholar 

  8. Bercovitz Z (1930) The pupillary test for the diagnosis of pregnancy. Am J Obstet Gynecol 19:882

    Google Scholar 

  9. Dinn RB, Harris A, Marcus PS (2003) Ocular changes in pregnancy. Obstet Gynecol Surv 58:137–144

    PubMed  Google Scholar 

  10. Chew EY, Mills JL, Metzger BE et al (1995) Metabolic control and progression of retinopathy. The diabetes in early pregnancy study. National institute of child health and human development diabetes in early pregnancy study. Diabetes care 18:631–637

    Article  CAS  PubMed  Google Scholar 

  11. Schultz KL, Birnbaum AD, Goldstein DA (2005) Ocular disease in pregnancy. Curr Opin Ophthalmol 16:308–314

    Article  PubMed  Google Scholar 

  12. Haeri S, Khoury J, Kovilam O, Miodovnik M (2008) The association of intrauterine growth abnormalities in women with type 1 diabetes mellitus complicated by vasculopathy. Am J Obstet Gynecol 199:278.e1–5

    Article  PubMed  Google Scholar 

  13. Howarth C, Gazis A, James D (2007) Associations of type 1 diabetes mellitus, maternal vascular disease and complications of pregnancy. Diabet Med 24:1229–1234

    Article  CAS  PubMed  Google Scholar 

  14. Gass JD (1991) Central serous chorioretinopathy and white subretinal exudation during pregnancy. Arch Ophthalmol 109:677–681

    CAS  PubMed  Google Scholar 

  15. Di Mario S, Basevi V, Gagliotti C et al (2009) Prenatal education for congenital toxoplasmosis. Cochrane Database Syst Rev CD006171

  16. Montoya JG, Remington JS (2008) Management of toxoplasma gondii infection during pregnancy. Clin Infect Dis 47:554–566

    Article  PubMed  Google Scholar 

  17. Shields CL, Shields JA, Eagle RC et al (1991) Uveal melanoma and pregnancy. A report of 16 cases. Ophthalmology 98:1667–1673

    CAS  PubMed  Google Scholar 

  18. Hart NC, Junemann AG, Siemer J et al (2007) Eye disease and mode of delivery. Z Geburtshilfe Neonatol 211:139–141

    Article  CAS  PubMed  Google Scholar 

  19. Heinonen O, Slone D, Shapiro S (1977) Birth defects and drugs in pregnancy. Publishing Sciences Group, Littleton (MA)

  20. Nishimura H, Tanimura T (1976) Clinical aspects of the teratogenicity of drugs. American Elsevier, New York (NY)

  21. Shepard T (1980) Catalog of teratogenic agents. Johns Hopkins University Press, Baltimore (MD)

  22. Czeizel AE, Rockenbauer M, Olsen J, Sorensen HT (2000) A teratological study of aminoglycoside antibiotic treatment during pregnancy. Scand J Infect Dis 32:309–313

    Article  CAS  PubMed  Google Scholar 

  23. Schaefer C, Amoura-Elefant E, Vial T et al (1996) Pregnancy outcome after prenatal quinolone exposure. Evaluation of a case registry of the European network of teratology information services (entis). Eur J Obstet Gynecol Reprod Biol 69:83–89

    Article  CAS  PubMed  Google Scholar 

  24. Loebstein R, Addis A, Ho E et al (1998) Pregnancy outcome following gestational exposure to fluoroquinolones: A multicenter prospective controlled study. Antimicrob Agents Chemother 42:1336–1339

    CAS  PubMed  Google Scholar 

  25. Petrou P, Georgalas I, Giavaras G et al (2009) Early loss of pregnancy after intravitreal bevacizumab injection. Acta Ophthalmol

  26. Bundesverband der Pharmazeutischen Industrie e. V. (2010) Arzneimittel in Schwangerschaft und Stillzeit. In: Rote Liste®. Rote Liste® Service GmbH, S. 2161–2162

  27. Food and Drug Administration (1982) FDA Drug Bulletin. S. 25

Download references

Author information

Authors and Affiliations

  1. Schwerpunkt Uveitis, Universitäts-Augenklinik Freiburg, Killianstr. 5, 79106, Freiburg, Deutschland

    T. Neß

  2. Institut für Reproduktionstoxikologie Ravensburg, Ravensburg, Deutschland

    W. Paulus

Authors
  1. T. Neß
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Paulus
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T. Neß.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Neß, T., Paulus, W. Auge und Schwangerschaft. Ophthalmologe 107, 863–873 (2010). https://doi.org/10.1007/s00347-010-2203-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00347-010-2203-y

Schlüsselwörter

Keywords

Search

Navigation